Plasma Exchange: An Effective Rescue Therapy in Critically Ill Patients With Coronavirus Disease 2019 Infection.
Journal
Critical care medicine
ISSN: 1530-0293
Titre abrégé: Crit Care Med
Pays: United States
ID NLM: 0355501
Informations de publication
Date de publication:
12 2020
12 2020
Historique:
pubmed:
25
8
2020
medline:
22
12
2020
entrez:
25
8
2020
Statut:
ppublish
Résumé
Infection by severe acute respiratory syndrome coronavirus-2 can induce uncontrolled systemic inflammation and multiple organ failure. The aim of this study was to evaluate if plasma exchange, through the removal of circulating mediators, can be used as rescue therapy in these patients. Single center case series. Local study. Four critically ill adults with coronavirus disease 19 pneumonia that failed conventional interventions. Plasma exchange. Two to six sessions (1.2 plasma volumes). Human albumin (5%) was used as the main replacement fluid. Fresh frozen plasma and immunoglobulins were administered after each session to avoid coagulopathy and hypogammaglobulinemia. Serum markers of inflammation and macrophage activation. All patients showed a dramatic reduction in inflammatory markers, including the main cytokines, and improved severity scores after plasma exchange. All survived to ICU admission. Plasma exchange mitigates cytokine storm, reverses organ failure, and could improve survival in critically ill patients with coronavirus disease 2019 infection.
Identifiants
pubmed: 32833695
doi: 10.1097/CCM.0000000000004613
pmc: PMC7493773
pii: 00003246-202012000-00070
doi:
Substances chimiques
Cytokines
0
Inflammation Mediators
0
Types de publication
Case Reports
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1350-e1355Commentaires et corrections
Type : CommentIn
Type : CommentIn
Type : CommentIn
Références
J Hepatol. 2014 Aug;61(2):396-407
pubmed: 24751830
Clin Infect Dis. 2020 Jul 28;71(15):762-768
pubmed: 32161940
Nat Rev Immunol. 2020 May;20(5):269-270
pubmed: 32273594
Br J Haematol. 2014 Feb;164(3):342-51
pubmed: 24172059
JAMA Intern Med. 2020 Jul 1;180(7):934-943
pubmed: 32167524
Lancet. 2020 Mar 28;395(10229):1033-1034
pubmed: 32192578
Clin Exp Immunol. 2004 Apr;136(1):95-103
pubmed: 15030519
Pediatr Crit Care Med. 2011 Mar;12(2):e87-9
pubmed: 20453703
Sci Rep. 2016 May 05;6:25359
pubmed: 27146253
J Clin Apher. 2018 Feb;33(1):117-120
pubmed: 28730667
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Crit Care Med. 2016 Feb;44(2):275-81
pubmed: 26584195
Autoimmun Rev. 2020 Jun;19(6):102537
pubmed: 32251717